Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Eskens FA"'
Autor:
Rodenburg RJ, Eskens FALM
Publikováno v:
International Journal of Nephrology and Renovascular Disease, Vol Volume 12, Pp 137-141 (2019)
RJ Rodenburg, FALM EskensErasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, The NetherlandsAbstract: Tivozanib is an oral selective vascular endothelial growth factors receptor (VEGFR) tyrosine kinase inhibitor that is recently a
Externí odkaz:
https://doaj.org/article/ab6acb34e8de4e75b35d8c1bb345e604
Autor:
Eskens FA, Steeghs N, Verweij J, Bloem JL, Christensen O, van Doorn L, Ouwerkerk J, de Jonge MJ, Nortier JW, Kraetzschmar J, Rajagopalan P, Gelderblom H
Publikováno v:
Journal of Clinical Oncology; 9/1/2009, Vol. 27 Issue 25, p4169-4176, 8p
Autor:
Puglisi M; Drug Development Unit, Institute of Cancer Research/The Royal Marsden, Downs Road, Sutton, Surrey, SM2 5PT, UK., Molife LR; Drug Development Unit, Institute of Cancer Research/The Royal Marsden, Downs Road, Sutton, Surrey, SM2 5PT, UK., de Jonge MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 2040, 3000 CA Rotterdam, The Netherlands., Khan KH; UCL Cancer Institute, University College London Hospital, Gower Street, London, WC1E 6BT, UK., Doorn LV; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 2040, 3000 CA Rotterdam, The Netherlands., Forster MD; UCL Cancer Institute, University College London Hospital, Gower Street, London, WC1E 6BT, UK., Blanco M; Drug Development Unit, Institute of Cancer Research/The Royal Marsden, Downs Road, Sutton, Surrey, SM2 5PT, UK., Gutierrez M; John Theurer Cancer Center, Hackensack University Medical Center, 92 2nd St, Hackensack, NJ 07601, USA., Franklin C; AbbVie, Inc, 1 North Waukegan Road, North Chicago, IL 60064, USA., Busman T; AbbVie, Inc, 1 North Waukegan Road, North Chicago, IL 60064, USA., Yang J; AbbVie, Inc, 1 North Waukegan Road, North Chicago, IL 60064, USA., Eskens FA; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 2040, 3000 CA Rotterdam, The Netherlands.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2021 Jul; Vol. 17 (21), pp. 2747-2758. Date of Electronic Publication: 2021 Apr 14.
Autor:
Mackay TM; 1Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam., van Rijssen LB; 1Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam., Andriessen JO; 1Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam., Suker M; 2Department of Surgery, Erasmus Medical Center, Rotterdam., Creemers GJ; 3Department of Medical Oncology, Catharina Hospital, Eindhoven., Eskens FA; 4Department of Medical Oncology, Erasmus Medical Center, Rotterdam., de Hingh IH; 5Department of Surgery, Catharina Hospital, Eindhoven., van de Poll-Franse LV; 6Department of Medical Psychology, Tilburg University, Tilburg.; 7Department of Psychosocial Oncology and Epidemiology, Netherlands Cancer Institute, Amsterdam.; 8Netherlands Comprehensive Cancer Organization, Utrecht; and., Sprangers MAG; 9Department of Psychology, and., Busch OR; 1Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam., Wilmink JW; 10Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Eijck CH; 2Department of Surgery, Erasmus Medical Center, Rotterdam., Besselink MG; 1Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam., van Laarhoven HW; 10Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2020 Jun; Vol. 18 (6), pp. 704-711.
Autor:
Nieuweboer AJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., de Graan AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Elbouazzaoui S; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Eskens FA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Hamberg P; Department of Internal Medicine, St. Franciscus Gasthuis, Rotterdam, The Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Sparreboom A; Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN, USA., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Schaik RH; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
The pharmacogenomics journal [Pharmacogenomics J] 2016 Nov; Vol. 16 (6), pp. 519-524. Date of Electronic Publication: 2015 Sep 08.
Autor:
Benson AB 3rd; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois. a-benson@northwestern.edu., Kiss I; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Bridgewater J; University College London Cancer Institute, London, United Kingdom., Eskens FA; Eramus MC Cancer Institute, Rotterdam, the Netherlands., Sasse C; Astellas Pharma Global Development, Northbrook, Illinois., Vossen S; Astellas Pharma Global Development, Northbrook, Illinois., Chen J; Astellas Pharma Global Development, Northbrook, Illinois., Van Sant C; Astellas Pharma Global Development, Northbrook, Illinois., Ball HA; Astellas Pharma Global Development, Northbrook, Illinois., Keating A; Astellas Pharma Global Development, Northbrook, Illinois., Krivoshik A; Astellas Pharma Global Development, Northbrook, Illinois.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Oct 15; Vol. 22 (20), pp. 5058-5067. Date of Electronic Publication: 2016 Jul 11.
Autor:
Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Lenting A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., El Bouazzaoui S; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., van Doorn L; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Eskens FA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Schaik RH; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Pharmacogenomics [Pharmacogenomics] 2016 Sep; Vol. 17 (14), pp. 1483-90. Date of Electronic Publication: 2016 Aug 17.
Autor:
Erdmann JI; Department of Surgery, Erasmus MC, Rotterdam, The Netherlands, j.i.erdmann@umcg.nl., Eskens FA, Vollmer CM, Kok NF, Groot Koerkamp B, Biermann K, van Eijck CH
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2015 Jul; Vol. 22 (7), pp. 2401-7. Date of Electronic Publication: 2014 Dec 12.
Autor:
Ayez N; Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands. n.ayez@erasmusmc.nl., van der Stok EP; Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands. e.vanderstok@erasmusmc.nl., de Wilt H; Department of Surgical Oncology, Radboud University, Nijmegen Medical Center, Nijmegen, The Netherlands. hans.dewilt@radboudumc.nl., Radema SA; Department of Medical Oncology, Radboud University, Nijmegen Medical Center, Nijmegen, The Netherlands. sandra.radema@radboudumc.nl., van Hillegersberg R; Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. r.vanhillegersberg@umcutrecht.nl., Roumen RM; Department of Surgery, Máxima Medical Center, Veldhoven, The Netherlands. r.roumen@mmc.nl., Vreugdenhil G; Department of Medical Oncology, Máxima Medical Center, Veldhoven, The Netherlands. g.vreugdenhil@mmc.nl., Tanis PJ; Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands. p.j.tanis@amc.nl., Punt CJ; Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands. c.punt@amc.uva.nl., Dejong CH; Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands. chc.dejong@mumc.nl., Jansen RL; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands. rob.jansen@mumc.nl., Verheul HM; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. h.verheul@vumc.nl., de Jong KP; Division of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. k.p.de.jong@umcg.nl., Hospers GA; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands. g.a.p.hospers@umcg.nl., Klaase JM; Department of Surgery, Medisch Spectrum Twente, Enschede, The Netherlands. j.klaase@mst.nl., Legdeur MC; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands. m.legdeur@mst.nl., van Meerten E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. e.vanmeerten@erasmusmc.nl., Eskens FA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. f.eskens@erasmusmc.nl., van der Meer N; Clinical Trial Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. n.vandermeer@erasmusmc.nl., van der Holt B; Clinical Trial Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. b.vanderholt@erasmusmc.nl., Verhoef C; Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands. c.verhoef@erasmusmc.nl., Grünhagen DJ; Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands. d.grunhagen@erasmusmc.nl.
Publikováno v:
BMC cancer [BMC Cancer] 2015 Mar 26; Vol. 15, pp. 180. Date of Electronic Publication: 2015 Mar 26.
Autor:
Oldenhuis CN; Department of Medical Oncology, University Medical Center Groningen (UMCG), Groningen, The Netherlands., Loos WJ; Department of Medical Oncology, Erasmus University Cancer Institute, Rotterdam, The Netherlands., Esteves B; AVEO Oncology, Cambridge, MA., van Doorn L; Department of Medical Oncology, Erasmus University Cancer Institute, Rotterdam, The Netherlands., Cotreau MM; AVEO Oncology, Cambridge, MA., Strahs AL; AVEO Oncology, Cambridge, MA., den Hollander MW; Department of Medical Oncology, University Medical Center Groningen (UMCG), Groningen, The Netherlands., Gietema JA; Department of Medical Oncology, University Medical Center Groningen (UMCG), Groningen, The Netherlands., de Vries EG; Department of Medical Oncology, University Medical Center Groningen (UMCG), Groningen, The Netherlands., Eskens FA; Department of Medical Oncology, Erasmus University Cancer Institute, Rotterdam, The Netherlands. Electronic address: f.eskens@erasmusmc.nl.
Publikováno v:
Clinical colorectal cancer [Clin Colorectal Cancer] 2015 Mar; Vol. 14 (1), pp. 18-24.e1. Date of Electronic Publication: 2014 Dec 16.